Indian IT Firm and Israeli Proteomics Shop to Develop Lead Compounds for Pharma | GenomeWeb

NEW YORK, Oct. 21 (GenomeWeb News) - Tata Consultancy Services of Mombai, India, and Israeli pharma BioStrx will co-develop lead drug compounds, the companies said last week.

 

The companies will collaborate on protein crystallization and structure determination to provide optimized lead compounds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.